CU6 1.17% $5.09 clarity pharmaceuticals ltd

Ann: First patient treated in theranostic prostate cancer trial

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.